Valeant Pharmaceuticals International Inc $134.42

up +1.19


24/4/2014 04:15 PM  |  NYSE : VRX  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get VRX Trend Analysis - it has outperformed the S&P 500 by 59%

Partner Headlines

  1. Benzinga's M&A Chatter for Wednesday April 23, 2014

    Benzinga
  2. Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical ...

    GuruFocus
  3. Forest Laboratories Is an Option for Wealthy Investors Who Could Afford ...

    GuruFocus
  4. Carl Icahn on Apple, Ackman and Valeant, and Seeding Activist Funds

    GuruFocus
  5. Bill Ackman Discusses Valeant on CNBC

    GuruFocus
  6. Big Pharmas Swap Specialties

    IBD
  7. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  8. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  9. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  10. Jeff Ubben on Valeant and Microsoft

    GuruFocus
  11. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  12. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  13. Ackman: No Laws Broken in Allergan Buy

    FoxBusiness
  14. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  15. Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as ...

    Benzinga
  16. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  17. Nasdaq, Health Care Lead Stock Market Higher

    IBD
  18. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  19. Valeant Bid For Allergan Draws Mixed Reaction

    IBD
  20. Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares ...

    Benzinga
  21. UPDATE: Allergan Confirms Receipt of Unsolicited Proposal from Valeant, ...

    Benzinga
  22. Mid-Morning Market Update: Markets Gain; McDonald's Posts Lower Profit

    Benzinga
  23. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  24. Stocks Hitting 52-Week Highs

    Benzinga
  25. Morning Market Movers

    Benzinga
  26. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  29. ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, ...

    Benzinga
  30. UPDATE: Valeant Proposes to Combine with Allergan at $48.30/Cash, 0.83 ...

    Benzinga
  31. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  32. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  33. Benzinga's M&A Chatter for Monday April 21, 2014

    Benzinga
  34. Valeant, Ackman Eye Allergan

    IBD
  35. Allergan and Valeant Rally on News of Potential Three Way Deal With Pershing ...

    Benzinga
  36. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  37. Pershing, Valeant Team Up in Bid to Buy Allergan

    FoxBusiness
  38. Facebook, Walgreen Climb Monday On International News

    IBD
  39. Nasdaq Finishes Near 4000 Level In Another Sell-Off

    IBD
  40. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  41. Ethical Drug Stocks Are Struggling

    IBD
  42. IBD 50 Stocks Fade With Market; Some Trip Sell Rules

    IBD
  43. Top Guru-Held Canadian Stocks

    GuruFocus
  44. Drug, Airline Stocks Top Shortened Weekly Review

    IBD
  45. Selling Pressure Builds In Leading Growth Stocks, Nasdaq

    IBD
  46. Top Industry Groups Take Big Hits In Market Sell-Off

    IBD
  47. 'We do not rely on Wall Street-generated research' - A Look at Former Buffett ...

    GuruFocus
  48. Biotechs, Medicals Get Hurt Amid Price-Inquiry News

    IBD
  49. Tableau, Vertex, Wynn Setting Up Follow-On Buy Areas

    IBD
  50. Tableau, Vertex, Wynn Setting Up Follow-On Buy Areas

    IBD
Trading Center